Statements (32)
Predicate | Object |
---|---|
gptkbp:instanceOf |
gptkb:biotechnology
|
gptkbp:CEO |
gptkb:A._Vaidheesh
|
gptkbp:country |
gptkb:India
|
gptkbp:formerName |
gptkb:Glaxo_India_Limited
|
gptkbp:foundedYear |
1924
|
gptkbp:headquartersLocation |
gptkb:Mumbai
|
https://www.w3.org/2000/01/rdf-schema#label |
GSK India
|
gptkbp:industry |
Pharmaceuticals
|
gptkbp:ISIN |
INE159A01016
|
gptkbp:listedOn |
gptkb:Bombay_Stock_Exchange
gptkb:National_Stock_Exchange_of_India |
gptkbp:notableProduct |
gptkb:Betnovate
gptkb:Calpol gptkb:Ceftum gptkb:Crocin gptkb:Zinetac gptkb:Sensodyne gptkb:Augmentin gptkb:Horlicks |
gptkbp:numberOfEmployees |
over 4000
|
gptkbp:parentCompany |
GlaxoSmithKline
|
gptkbp:product |
Consumer healthcare products
Vaccines Prescription medicines |
gptkbp:stockExchange |
gptkb:NSE
BSE |
gptkbp:stockSymbol |
gptkb:GLAXO
|
gptkbp:subsidiary |
gptkb:GlaxoSmithKline_plc
|
gptkbp:type |
gptkb:public_company
|
gptkbp:website |
https://india-pharma.gsk.com/
|
gptkbp:bfsParent |
gptkb:Gurgaon
|
gptkbp:bfsLayer |
5
|